Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | 0.00% | -16.67% | -54.55% |
05-14 | Bioxyne to Release Shares from Escrow; Shares Up 17% | MT |
05-14 | Bioxyne Subsidiary, CY Biopharma Enter Partnership to Advance Novel Psilocybin Therapies in Australia | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
6.79M | - | - | - | - | - | |
54.63B | - | |||||
39.92B | ||||||
38.82B | ||||||
26.86B | ||||||
26.22B |
- Stock Market
- Equities
- BXN Stock
- Charts Bioxyne Limited
- Sector Chart